|
ATCC
vr 1616 Vr 1616, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/rAAV2+RSS%3B+Reference+material/pmc07196056-152-6-5 Average 92 stars, based on 1 article reviews
vr 1616 - by Bioz Stars,
2026-11
92/100 stars
|
Buy from Supplier |
|
Genechem
raav2 Raav2, supplied by Genechem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/9+camkii+drd1+egfp+raav2+rnai/10__1172_slash_jci196944-282-15-24 Average 86 stars, based on 1 article reviews
raav2 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
Addgene inc
paav2 retro Paav2 Retro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/rAAV2-retro+helper+(Plasmid+%2381070)/10__1016_slash_j__jphs__2025__06__004-37-18-22 Average 95 stars, based on 1 article reviews
paav2 retro - by Bioz Stars,
2026-11
95/100 stars
|
Buy from Supplier |
|
PackGene Biotech lnc
aav2 cas9 ![]() Aav2 Cas9, supplied by PackGene Biotech lnc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/AAV2+Vector+Production/pmc12930510-150-8-14 Average 96 stars, based on 1 article reviews
aav2 cas9 - by Bioz Stars,
2026-11
96/100 stars
|
Buy from Supplier |
|
Addgene inc
raav2 retro ![]() Raav2 Retro, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/rAAV2-retro+(Plasmid+%2383283)/bio_rxiv__488585-116-13-26 Average 94 stars, based on 1 article reviews
raav2 retro - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
Gensight Inc
raav2.7m8-cag-chrimsonr-tdtomato (gs030) ![]() Raav2.7m8 Cag Chrimsonr Tdtomato (Gs030), supplied by Gensight Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/raav2+2+nd4/pmc07352801__ijms___21___04197___s001-38-0-0 Average 90 stars, based on 1 article reviews
raav2.7m8-cag-chrimsonr-tdtomato (gs030) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Janvier Labs
modified raav2-gfp ![]() Modified Raav2 Gfp, supplied by Janvier Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/unmodified+raav2/us11382988-541-15-13 Average 90 stars, based on 1 article reviews
modified raav2-gfp - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Sangamo Inc
bdd-fviii ![]() Bdd Fviii, supplied by Sangamo Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/raav2+6/pmc07132613-28-8-0 Average 90 stars, based on 1 article reviews
bdd-fviii - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Applied Genetic Technologies Corporation
raav2-cb-hrpe65 ![]() Raav2 Cb Hrpe65, supplied by Applied Genetic Technologies Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/raav2+cbhrpe65/pmc07701157-63-9-11 Average 90 stars, based on 1 article reviews
raav2-cb-hrpe65 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Promega
β-galactosidase assay raav-2-lacz ![]() β Galactosidase Assay Raav 2 Lacz, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/%CE%B2+galactosidase+assay+raav+2+lacz/pmc01606626-35-9-44 Average 90 stars, based on 1 article reviews
β-galactosidase assay raav-2-lacz - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
VectorBuilder GmbH
raav2-colq-myc ![]() Raav2 Colq Myc, supplied by VectorBuilder GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/or+containing+only+the+sequence+coding+for+egfp++raav2+egfp+/pm37356721-337-40-55 Average 90 stars, based on 1 article reviews
raav2-colq-myc - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Albaugh LLC
raav2-retro ![]() Raav2 Retro, supplied by Albaugh LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/raav2/raav2+retro/pmc09559170-45-2-21 Average 90 stars, based on 1 article reviews
raav2-retro - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: ACS Synthetic Biology
Article Title: Enhanced Epigenetic Modulation via mRNA-Encapsulated Lipid Nanoparticles Enables Targeted Anti-inflammatory Control
doi: 10.1021/acssynbio.5c00188
Figure Lengend Snippet: Co-delivery of Myd88 repressor ZFR11 and gene therapy related antigen modulates humoral immunity in AAV preimmunized mice. (A) Schematic representation of experimental design. C57BL/6J mice received two retro-orbital injections of AAV2-GFP (5 × 10 11 GC) 2 weeks apart. Two weeks later, mice were administered weekly doses of LNP-encapsulated mRNA (0.7 mg kg –1 ) encoding either ZFR11-VP1-mCherry ( N = 10), VP1 only ( N = 10), or no LNP/PBS control ( N = 6) for 4 weeks. Two weeks after the final vaccination, mice received a single intravenous coinjection of AAV2-mCherry (5 × 10 11 GC) and ZFR11-LNP (0.7 mg kg –1 ). Analyses were performed 3 weeks post-AAV2 challenge. (B) qRT-PCR analysis of mCherry expression in liver and lung tissues ( N = 8–10 mice per treatment group, N = 6 for PBS). Data are presented as mean ± SEM Statistical analysis was performed using one-way ANOVA followed by Dunnett’s multiple comparisons test. * P ≤ 0.05 was considered statistically significant (C) Left: Representative immunohistochemical staining for mCherry in liver sections. Right: Quantification of mCherry staining intensity (ZFR11-VP1-mCherry-306O 10 : N = 9, PBS: N = 5, staining negative control/mCherry uninjected: N = 2). Data are presented as mean ± SEM Statistical analysis was performed using one-way ANOVA followed by Dunnett’s multiple comparisons test. * P ≤ 0.05 was considered statistically significant. (D) ELISA measurement of plasma anti-AAV2 total IgG and IgG2b levels. Results shown as fold change in optical density at day 35 (2 weeks postvaccination) relative to day 0 (prevaccination baseline) ( N = 9–10 per treatment group, N = 6 for PBS). Statistical analysis was performed using one-way ANOVA followed by Dunnett’s multiple comparisons test. * P ≤ 0.05 was considered significant. (E) ELISA measurement of serum anti-AAV2 neutralizing antibody levels showing a 32% reduction in the ZFR11-VP1-mCherry group compared to VP1 control at day 35 (2 weeks postvaccination) relative to day 0 (prevaccination baseline) ( N = 9–10 mice per treatment group, N = 6 mice for PBS). Statistical analysis was performed using the unpaired parametric t test. * P ≤ 0.05 was considered significant. (F) Time-point analysis of plasma total IgG, IgG2b, and neutralizing antibodies titers in Relative Light Units (RLU) at day 0 (prevaccination baseline), day 35 (2 weeks postvaccination), and day 45 (10 days after AAV2-mCherry rechallenge) ( N = 9–10 per treatment group).
Article Snippet: Following validation, these constructs served as templates for AAV2-Cas9 and
Techniques: Control, Quantitative RT-PCR, Expressing, Immunohistochemical staining, Staining, Negative Control, Enzyme-linked Immunosorbent Assay, Clinical Proteomics
Journal: bioRxiv
Article Title: Improved yield of AAV2 and rAAV2-retro serotypes following sugar supplementation during the viral production phase
doi: 10.1101/488585
Figure Lengend Snippet: AAV yields after sucrose treatment in a large scale production. AAVpro 293T cells were triple transfected with a transfer plasmid, a plasmid encoding rep and serotype specific cap genes and a plasmid encoding the adenoviral helper sequences. The following day media was replaced with fresh DMEM with or without 0.1M sucrose. Cells and media were harvested 96h post transfection and viral particles purified via iodixanol gradient ultracentrifugation followed by concentration and buffer exchange. For each serotype between 2 (AAV2) and 4 (rAAV2-retro and AAV5) different preps were prepared and the range and average number of AAV genome copies (GC) calculated and plotted, A. B, the average fold change of sucrose to untreated viral prep was calculated and plotted.
Article Snippet: Given these promising results, we decided to test the sucrose supplementation strategy on
Techniques: Transfection, Plasmid Preparation, Purification, Concentration Assay, Buffer Exchange
Journal: bioRxiv
Article Title: Improved yield of AAV2 and rAAV2-retro serotypes following sugar supplementation during the viral production phase
doi: 10.1101/488585
Figure Lengend Snippet: AAVpro 293T cells were triple transfected with a plasmid encoding jGCaMP7f (Addgene number 104488), a plasmid encoding rep and rAAV2-retro cap genes (Addgene number 81070) and a plasmid encoding the adenoviral helper sequences. The following day media was replaced with fresh DMEM with or without 0.1M of the indicated sugar. Cells and media were harvested 96h post transfection and viral particles purified via iodixanol gradient ultracentrifugation followed by concentration and buffer exchange. A, following buffer exchange, the level of sucrose or sorbitol was measured in the final preparations as compared to a standards of known concentration. B, Neuro2a cells were transduced with approximately 1.5 × 10 6 vector particles per cell from the untreated and sucrose treated viral preparations. GCaMP7f expression was assessed 96h post transduction. C, purity of the final untreated and sucrose treated preparations was assessed via SDS-PAGE followed by silver staining.
Article Snippet: Given these promising results, we decided to test the sucrose supplementation strategy on
Techniques: Transfection, Plasmid Preparation, Purification, Concentration Assay, Buffer Exchange, Transduction, Expressing, SDS Page, Silver Staining
Journal: bioRxiv
Article Title: Improved yield of AAV2 and rAAV2-retro serotypes following sugar supplementation during the viral production phase
doi: 10.1101/488585
Figure Lengend Snippet: A, AAVpro 293T were left untreated (top panels) or treated with 0.1M sucrose (bottom panels) for 72 hours. The level of endocytosis of untreated and sucrose-treated cells was assessed via internalization of the pH sensitive pHrodo green dextran dye. B, AAVpro 293T cells were transduced with CAG-GFP rAAV2-retro in the absence (top panels) or presence (bottom panels) of 0.1M sucrose. 72h later, cells GFP expression was assessed by direct fluorescence.
Article Snippet: Given these promising results, we decided to test the sucrose supplementation strategy on
Techniques: Transduction, Expressing, Fluorescence